Magnet Biomedicine Appoints Nick Vlahakis as New Chief Medical Officer to Drive Clinical Development Magnet Biomedicine has appointed Dr. Nick Vlahakis as Chief Medical Officer to advance its clinical development strategy and molecular glue therapeutics pipeline.

Magnet Biomedicine Appoints Nick Vlahakis as New Chief Medical Officer to Drive Clinical Development #USA #Boston #molecular_glue #Magnet_Biomedicine #Nick_Vlahakis

Magnet Biomedicine Strengthens Leadership with Appointment of Dr. Bharat Reddy as Chief Business Officer Magnet Biomedicine has appointed Dr. Bharat Reddy as its Chief Business Officer, bringing over a decade of biopharma experience to the role.

Magnet Biomedicine Strengthens Leadership with Appointment of Dr. Bharat Reddy as Chief Business Officer #USA #Cambridge #Magnet_Biomedicine #Bharat_Reddy #TrueGlue

Magnet Biomedicine Chooses Ledger™ Platform for Enhanced Compound Management Innovation Magnet Biomedicine partners with Simplicis's Ledger™ platform to elevate compound management, streamline operations, and enhance innovation in molecular glue research.

Magnet Biomedicine Chooses Ledger™ Platform for Enhanced Compound Management Innovation #USA #Boston #Magnet_Biomedicine #Simplicis #Leder™_Platform

Magnet Biomedicine and Lilly Join Forces for Innovative Molecular Glue Therapies Magnet Biomedicine announces a strategic collaboration with Lilly to develop groundbreaking molecular glue medicines for oncology, enhancing therapeutic options.

Magnet Biomedicine and Lilly Join Forces for Innovative Molecular Glue Therapies #USA #Boston #Lilly #molecular_glue #Magnet_Biomedicine